Plasma viral load and genotypic resistance patterns in children adding lamivudine to current reverse transcriptase inhibitor therapy (PENTA 4 Trial)

18 Apr, 1998

Authors:  Kaye S, Loveday C, Gibb DM., Newberry A. Published in: 4th International Congress, November 8ht-12th 1998, Glasgow.  P_305
Read More

A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial

12 Apr, 1998

Authors: Aboulker JP, Babiker A, Carrière I, et al. Published in: AIDS.1998;12(14):F151-F160 Objective To evaluate the toxicity, tolerability and effect on laboratory markers of adding lamivudine (3TC) to nucleoside analogue…
Read More